久久久欧美日韩免费观看|国产又粗又硬又长又爽|无码不卡视频在线观看|欧美色一区二区三区四区|久草新视频在线观看12|亚洲国产精品人人做人人爱

Sorry, you are not login!
VIP members can check the contents after login.
Click to login

  • TOP
  • Moblie
    All Prompt Messages

    Tradesns Foreign Trade Community
    Current page location: Home Page > Article > Theaters to stage new Mandarin versions of Shakespeare plays
    Theaters to stage new Mandarin versions of Shakespeare plays
    Browse volume:3093 | Reply:0 | Release time:2018-04-04 11:24:21

    New productions of the William Shakespeare plays Hamlet, Twelfth Night, and The Tempest - and all using Mandarin translations - will be staged in China this year.

    During the development of the Mandarin versions of Shakespeare's plays, the Royal Shakespeare Company is inviting companies of actors, directors, and playwrights from China and the UK to work with translators during rehearsal workshops. [Photo: China Plus]

    The Royal Shakespeare Company has commissioned the new translations as part of its Shakespeare Folio Project. The project aims to make the playwright's work more accessible to Chinese speakers.

    China's National Centre for the Performing Arts will put on the new version of The Tempest in Beijing in August.

    The Guangzhou Dramatic Arts Centre will open its production of Twelfth Night in Guangzhou in October. And the Li Liuyi Theatre Studio in Beijing will premiere the new translation of Hamlet in December.

    During the development of the Mandarin versions of Shakespeare's plays, the Royal Shakespeare Company is inviting companies of actors, directors, and playwrights from China and the UK to work with translators during rehearsal workshops.

    Together they unpick clues about meaning, character, and pacing that Shakespeare put into the text, elements that the Company says were sometimes lost in previous translations.

    The Royal Shakespeare Company's artistic director Gregory Doran said the new translation process makes for more "actor and audience friendly translations" of Shakespeare's work.

    Concern (1
    Commentary(0)
    Share
    Popular
    Relevant